Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001069530-22-000043
Filing Date
2022-09-12
Accepted
2022-09-12 16:00:51
Documents
1
Period of Report
2022-09-08

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT certent-form4.html 4  
1 PRIMARY DOCUMENT certent-form4.xml 4 5209
  Complete submission text file 0001069530-22-000043.txt   6720
Mailing Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731
Business Address 7801 N CAPITAL OF TEXAS HIGHWAY SUITE 260 AUSTIN TX 78731 512-501-2444
CASSAVA SCIENCES INC (Issuer) CIK: 0001069530 (see all company filings)

EIN.: 911911336 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE LETTERMAN DRIVE BUILDING C SUITE 410 SAN FRANCISCO CA 94129
Business Address
ROBERTSON SANFORD (Reporting) CIK: 0001250105 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-29959 | Film No.: 221238585